Bill Text: IA HF543 | 2017-2018 | 87th General Assembly | Enrolled


Bill Title: A bill for an act relating to child in need of assistance and child abuse cases involving certain drugs and other substances. (Formerly HF 276.) Effective 7-1-17.

Spectrum: Committee Bill

Status: (Passed) 2017-04-20 - Signed by Governor. H.J. 1115. [HF543 Detail]

Download: Iowa-2017-HF543-Enrolled.html

House File 543 - Enrolled




                              HOUSE FILE       
                              BY  COMMITTEE ON HUMAN
                                  RESOURCES

                              (SUCCESSOR TO HF 276)
 \5
                                   A BILL FOR
 \1
                                         House File 543

                             AN ACT
 RELATING TO CHILD IN NEED OF ASSISTANCE AND CHILD ABUSE
    CASES INVOLVING CERTAIN DRUGS AND OTHER SUBSTANCES.

 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    Section 1.  Section 232.2, subsection 6, paragraph p, Code
 2017, is amended to read as follows:
    p.  Whose parent, guardian, or custodian, or other adult
 member of the household in which a child resides does any
 of the following:  unlawfully uses, possesses, manufactures,
 cultivates, or distributes a dangerous substance in the
 presence of a child,; or knowingly allows such use, possession,
  manufacture, cultivation, or distribution by another person
 in the presence of a child,; or in the presence of a child
  possesses a product containing ephedrine, its salts, optical
 isomers, salts of optical isomers, or pseudoephedrine, its
 salts, optical isomers, salts of optical isomers, with the
 intent to use the product as a precursor or an intermediary to
 a dangerous substance in the presence of a child; or unlawfully
 uses, possesses, manufactures, cultivates, or distributes a
 dangerous substance specified in subparagraph (2), subparagraph
 division (a), (b), or (c), in a child's home, on the premises,
 or in a motor vehicle located on the premises.
    (1)  For the purposes of this paragraph, "in the presence
 of a child" means in the physical presence of a child during
 the manufacture or possession, the manufacture or possession
 occurred in a child's home, on the premises, or in a motor
 vehicle located on the premises, or the manufacture or
 possession occurred or occurring under other circumstances
 in which a reasonably prudent person would know that the
 use, possession, manufacture or possession, cultivation, or
 distribution may be seen, smelled, ingested, or heard by a
 child.
    (2)  For the purposes of this paragraph, "dangerous
 substance" means any of the following:
    (a)  Amphetamine, its salts, isomers, or salts of its
 isomers.
    (b)  Methamphetamine, its salts, isomers, or salts of its
 isomers.
    (c)  A chemical or combination of chemicals that poses a
 reasonable risk of causing an explosion, fire, or other danger
 to the life or health of persons who are in the vicinity while
 the chemical or combination of chemicals is used or is intended
 to be used in any of the following:
    (i)  The process of manufacturing an illegal or controlled
 substance.
    (ii)  As a precursor in the manufacturing of an illegal or
 controlled substance.
    (iii)  As an intermediary in the manufacturing of an illegal
 or controlled substance.
    (d)  Cocaine, its salts, isomers, salts of its isomers, or
 derivatives.
    (e)  Heroin, its salts, isomers, salts of its isomers, or
 derivatives.
    (f)  Opium and opiate, and any salt, compound, derivative, or
 preparation of opium or opiate.
    Sec. 2.  Section 232.68, subsection 2, paragraph a,
 subparagraph (7), Code 2017, is amended to read as follows:
    (7)  The person responsible for the care of a child has,
 in the presence of the a child, as defined in section 232.2,
 subsection 6, paragraph "p", manufactured unlawfully uses,
 possesses, manufactures, cultivates, or distributes a dangerous
 substance, as defined in section 232.2, subsection 6, paragraph
 "p", or in the presence of the child knowingly allows such
 use, possession, manufacture, cultivation, or distribution
 by another person in the presence of a child; possesses a
 product containing ephedrine, its salts, optical isomers, salts
 of optical isomers, or pseudoephedrine, its salts, optical
 isomers, salts of optical isomers, with the intent to use
 the product as a precursor or an intermediary to a dangerous
 substance in the presence of a child; or unlawfully uses,
 possesses, manufactures, cultivates, or distributes a dangerous
 substance specified in section 232.2, subsection 6, paragraph
 "p", subparagraph (2), subparagraph division (a), (b), or (c),
 in a child's home, on the premises, or in a motor vehicle
 located on the premises.
    Sec. 3.  Section 232.77, subsection 2, Code 2017, is amended
 to read as follows:
    2.  a.  If a health practitioner discovers in a child
 physical or behavioral symptoms of the effects of exposure
 to cocaine, heroin, amphetamine, methamphetamine, or other
 illegal drugs, or combinations or derivatives thereof, which
 were not prescribed by a health practitioner, or if the health
 practitioner has determined through examination of the natural
 mother of the child that the child was exposed in utero, the
 health practitioner may perform or cause to be performed a
 medically relevant test, as defined in section 232.73, on the
 child. The practitioner shall report any positive results of
 such a test on the child to the department. The department
 shall begin an assessment pursuant to section 232.71B upon
 receipt of such a report. A positive test result obtained
 prior to the birth of a child shall not be used for the criminal
 prosecution of a parent for acts and omissions resulting in
 intrauterine exposure of the child to an illegal drug.
    b.  If a health practitioner involved in the delivery or
 care of a newborn or infant discovers in the newborn or infant
 physical or behavioral symptoms that are consistent with the
 effects of prenatal drug exposure or a fetal alcohol spectrum
 disorder, the health practitioner shall report such information
 to the department in a manner prescribed by rule of the
 department.


                                                                                            LINDA UPMEYER


                                                                                            JACK WHITVER


                                                                                            CARMINE BOAL


                                                                                            TERRY E. BRANSTA

                             -1-
feedback